i still hold abbv and isis since i like their prospects better
recently look at gsk at 52-week low for a pharma play = any suggestion?
for the next upturn i will exit 1/3 of holding
monitoring her like a hawk today = we shall see
zu is a big loser = stay away
vips stock action very weak for the past couple weeks = dont like it = stay away
sold regn holding at 399.50 and runnn for less than 24-hour hold
will be back at the next pull-back opportunity = merci bien $$$
i like gsk at the moment as a pharma play
as stock languishing at 52-week low due to tax loss selling
=== Solid companies have been sold to be used solely as write-offs, and you can gain from that
Shares of solid companies go on sale at this time of the year simply because it's the season for tax-loss selling.
Tax-loss selling hits stocks that have had a bad year. Investors want to dump them to beat the tax man by booking losses to offset gains.
=== But, come January, the tax-loss sellers are gone, and those stocks can rebound. Short-term traders might book quick profits.
gambino -- ibm went up +12 points at 162+ now since the bottom 151+ when I asked you whether you would buy more for your ibm holding
lock-up means nothing
look at fb lock-up date
look at yelp lock-up date
look at gpro lock-up date
... and learn something
there is a reason why ... no stock goes down with no news ... here it is to explain a drop in stock price ...
=== Shares of Alibaba Group (BABA) closed down 2.99% to $105.52 as its Tmall Global site "stumbles," with traffic on the shopping platform a fraction of that on Alibaba's other marketplaces, the Wall Street Journal reports.
=== In the stock market today, biotechs came under pressure. Biotech group fell more than 5% following a 1% loss Monday. Regeneron (NASDAQ:REGN) and Celgene (NASDAQ:CELG) sliced below their 50-day lines, falling 5% and 7% respectively.
Biogen Idec (NASDAQ:BIIB) also took a hit, falling 5%. It's still holding above its 50-day line. The sharp decline in biotechs could be a sign that institutional investors are ready to rotate out of a group that's been leading the market for months.
dumping gsk for tax loss? stock hovering close to 52-week low price ...
the laggard of this year may be a star of next year or vice versa?